Trial | NCT02017418  Report issue

Official Title

The Effects of a Zeaxanthin Intervention on Visuomotor Function

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    102
This study was designed to test whether two zeaxanthin formulations (supplements containing different nutritional compounds with zeaxanthin and omega fatty acids being the primary ingredients of interest) influenced visual motor function. Visual motor function refers to the processing speed of the visual system and how individuals respond behavioral to visual stimuli (e.g., reaction time).
This study was designed to test whether two zeaxanthin formulations (supplements containing different nutritional compounds with zeaxanthin and omega fatty acids being the primary ingredients of interest) influenced visual motor function. Visual motor function refers to the processing speed of the visual system and how individuals respond behavioral to visual stimuli (e.g., reaction time).
Study Started
Feb 29
2012
Primary Completion
Jul 31
2014
Study Completion
Jul 31
2014
Last Update
May 27
2015
Estimate

Dietary Supplement zeaxanthin

softgel

Dietary Supplement combinatory supplement

softgel

  • Other names: zeaxanthin + lutein + DHA

zeaxanthin Experimental

placebo zeaxanthin

combinatory supplement Active Comparator

placebo combinatory supplement

Criteria 

Inclusion Criteria:

Age: ≥18 and ≤ 40 years
BMI: ≥ 20 and ≤ 30 kg/m2
No anticipated changes in dieting habits (as relevant to the intake of xanthophylls and fats/oils).
No anticipated surgical procedures.
Willingness and ability to give written informed consent and willingness and ability to comply with the study requirements.
Corrected visual acuity (ETDRS): better than 20/60 in the eye selected for the study

Exclusion Criteria:

Smokers
Current or history of relevant ocular diseases (such as AMD) or other conditions e.g., lipid disorders.
Inability to reliably perform macular pigment optical density measurements by "Heterochromatic Flicker Photometry" or any of the other ophthalmic tests of the study.
Any condition likely to interfere with normal gastro-intestinal absorption of xanthophylls (e.g., digestive disorders: inflammatory bowel disease, ulcerative colitis, Crohn's, irritable bowel, etc. or lipid disorders including conditions such as hypercholesterolemia)
Current use of xanthophyll containing supplements or use of xanthophyll containing supplements in the past 6 months (but excluding multivitamins containing lutein or zeaxanthin at low potency).
Participation in any other study during last 1 month before study initiation.
Known hypersensitivity or allergy to xanthophylls.
Regular intake of medications or supplements, which the principal investigator deems likely to confound the study outcomes. These include diabetes medication and statins or any other drug/supplement to modulate cholesterol or fat digestion/absorption.
No Results Posted